IL10 and Alzheimer disease: Targeting of anti-inflammatory and pro-resolution mediators has also produced mixed results, with the activation of IL-10 anti-inflammatory signaling in AD mouse models resulting in impairment in Aβ phagocytosis and exacerbated AD neuropathology [107, 108].